Jacobs Levy Equity Management, Inc Alector, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Alector, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,322,882 shares of ALEC stock, worth $4.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,322,882
Previous 1,334,032
0.84%
Holding current value
$4.18 Million
Previous $1.64 Million
12.93%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ALEC
# of Institutions
140Shares Held
54.6MCall Options Held
29.8KPut Options Held
13.4K-
Black Rock Inc. New York, NY9.1MShares$28.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$18.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.88MShares$15.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$6.86 Million0.01% of portfolio
-
Eversept Partners, LP New York, NY1.99MShares$6.28 Million0.28% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $261M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...